ARTICLE | Distillery Therapeutics
Therapeutics: Variant surface antigen 2 chondroitin sulphate A (VAR2CSA); chondroitin sulfate proteoglycans (CSPG)
December 17, 2015 8:00 AM UTC
Patient sample, cell culture and mouse studies suggest VAR2CSA conjugated to cytotoxic agents could help treat cancer. In patients with various types of epithelial cancers, bone sarcomas or soft tissu...